Inspire Investing, LLC Sage Therapeutics, Inc. Transaction History

Inspire Investing, LLC

$858 Million
Q4 2024

A detailed history of Inspire Investing, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Inspire Investing, LLC holds 75,313 shares of SAGE stock, worth $538,487. This represents 0.05% of its overall portfolio holdings.

Number of Shares

75,313

Previous 57,772 30.36%

Holding current value

$538,487

Previous $416,000 1.92%

% of portfolio

0.05%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$4.78 - $8.57 $83,845 - $150,326	17,541 Added 30.36%	75,313 $408,000
Q3 2024 Oct 10, 2024	BUY	$7.02 - $13.08 $176,475 - $328,818	25,139 Added 77.04%	57,772 $416,000
Q2 2024 Aug 12, 2024	BUY	$10.58 - $17.9 $141,761 - $239,842	13,399 Added 69.66%	32,633 $354,000
Q1 2024 May 07, 2024	BUY	$18.62 - $26.95 $30,760 - $44,521	1,652 Added 9.4%	19,234 $360,000
Q4 2023 Feb 12, 2024	BUY	$17.1 - $22.26 $43,314 - $56,384	2,533 Added 16.83%	17,582 $381,000
Q3 2023 Oct 26, 2023	BUY	$16.75 - $48.98 $19,580 - $57,257	1,169 Added 8.42%	15,049 $309,000
Q2 2023 Jul 31, 2023	BUY	$40.65 - $59.54 $25,284 - $37,033	622 Added 4.69%	13,880 $652,000
Q1 2023 Apr 24, 2023	BUY	$37.27 - $46.57 $253,771 - $317,095	6,809 Added 105.58%	13,258 $556,000
Q4 2022 Jan 26, 2023	BUY	$32.2 - $43.61 $27,305 - $36,981	848 Added 15.14%	6,449 $0
Q3 2022 Nov 07, 2022	SELL	$32.28 - $43.27 $30,084 - $40,327	-932 Reduced 14.27%	5,601 $219,000
Q2 2022 Aug 10, 2022	SELL	$27.52 - $37.99 $574,920 - $793,649	-20,891 Reduced 76.18%	6,533 $211,000
Q1 2022 Apr 21, 2022	BUY	$30.71 - $45.71 $661,217 - $984,182	21,531 Added 365.37%	27,424 $908,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $218,394 - $277,619	5,893 New	5,893 $251,000
Q4 2021 Feb 03, 2022	SELL	$37.06 - $47.11 $190,784 - $242,522	-5,148 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$40.26 - $57.37 $45,171 - $64,369	1,122 Added 27.87%	5,148 $228,000
Q2 2021 Aug 10, 2021	SELL	$54.88 - $79.29 $584,087 - $843,883	-10,643 Reduced 72.55%	4,026 $229,000
Q1 2021 Apr 30, 2021	BUY	$70.65 - $96.76 $865,533 - $1.19 Million	12,251 Added 506.66%	14,669 $1.1 Million
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $141,235 - $215,347	2,418 New	2,418 $209,000
Q1 2018 Apr 13, 2018	SELL	$152.15 - $192.33 $53,404 - $67,507	-351 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$60.72 - $167.34 $21,312 - $58,736	351	351 $58,000

Others Institutions Holding SAGE

# of Institutions

194

Shares Held

45M

Call Options Held

304K

Put Options Held

117K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $425M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account

Inspire Investing, LLC Sage Therapeutics, Inc. Transaction History